These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 230927)

  • 41. Hypolipidemic effects of clofibrate and selected chroman analogs in fasted rats: I. Chow-fed animals.
    O'Brien M; Patel ST; Mukhopadhyay A; Newman HA; Feller DR; Kokrady SS; Witiak DT; Lanese RR; Rice JC
    Lipids; 1981 Dec; 16(12):903-11. PubMed ID: 7329211
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Binding to plasma lipoproteins of chlorophenoxyisobutyric, tibric and nicotinic acids and their esters: its significance for the mechanism of lipid lowering by clofibrate and related drugs.
    Beaumont JL; Dachet C
    Atherosclerosis; 1976; 25(2-3):255-66. PubMed ID: 188431
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of KC-9432, a new hypolipidemic compound, on high density lipoprotein cholesterol in rats.
    Seri K; Sato R; Hamazaki Y; Yamamoto T; Ishiyama N
    Atherosclerosis; 1980 Sep; 37(1):97-102. PubMed ID: 6893550
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of serum lipid profiles and hypertension on chronic renal allograft dysfunction.
    Hamidian Jahromi AR; Raiss-Jalali GA; Malekhosseini A; Jan-Ghorban P
    Transplant Proc; 2003 Feb; 35(1):259-62. PubMed ID: 12591390
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of amiodarone on blood lipids.
    Sonnenblick M; Gottlieb S; Goldstein R; Abraham AS
    Cardiology; 1986; 73(3):147-50. PubMed ID: 3719600
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coronary heart disease, cancer, lipoproteins, and the effects of clofibrate: is enzyme induction a common link and are lipoproteins red herrings?
    Heller RF
    Lancet; 1981 Dec; 2(8258):1258-60. PubMed ID: 6118672
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lipid and lipoprotein (a) concentrations in renal transplant patients.
    Webb AT; Plant M; Reaveley DA; O'Donnell M; Luck VA; O'Connor B; Seed M; Brown EA
    Nephrol Dial Transplant; 1992; 7(7):636-41. PubMed ID: 1353867
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of hyperlipidaemic diet and clofibrate treatment on rat erythrocyte lipids.
    Pelliniemi TT; Viikari J; Nieminen L
    Scand J Haematol; 1976 Aug; 17(2):117-22. PubMed ID: 968444
    [TBL] [Abstract][Full Text] [Related]  

  • 49. How soon after myocardial infarction should plasma lipid values be assessed?
    Ryder RE; Hayes TM; Mulligan IP; Kingswood JC; Williams S; Owens DR
    Br Med J (Clin Res Ed); 1984 Dec; 289(6459):1651-3. PubMed ID: 6439361
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics of clofibrate in familial hypercholesterolemia.
    Pichardo R; Boulet L; Davignon J
    Atherosclerosis; 1977 Apr; 26(4):573-82. PubMed ID: 193524
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of clofibrate on progression of coronary disease: a prospective angiographic study in man.
    Cohn K; Sakai FJ; Langston MF
    Am Heart J; 1975 May; 89(5):591-8. PubMed ID: 1091127
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and hypolipidaemic evaluation of a series of alpha-asarone analogues related to clofibrate in mice.
    Labarrios F; Garduño L; Vidal MR; Garcia R; Salazar M; Martinez E; Diaz F; Chamorro G; Tamariz J
    J Pharm Pharmacol; 1999 Jan; 51(1):1-7. PubMed ID: 10197410
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of alternate-day prednisone on plasma lipids in renal transplant recipients.
    Curtis JJ; Galla JH; Woodford SY; Lucas BA; Luke RG
    Kidney Int; 1982 Jul; 22(1):42-7. PubMed ID: 6750206
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the effects of halofenate (MK-185) and clofibrate on plasma lipid and uric acid concentration in hyperlipoproteinemic patients.
    Lisch HJ; Patsch J; Sailer S; Braunsteiner H
    Atherosclerosis; 1975; 21(3):391-9. PubMed ID: 1148032
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacologic effects of 4-chlorophenol in rats: comparison to clofibrate.
    Phornchirasilp S; Patel ST; Hanson JM; Newman HA; Witiak DT; Feller DR
    Proc Soc Exp Biol Med; 1989 Jun; 191(2):139-46. PubMed ID: 2726779
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic clofibrate therapy in maintenance hemodialysis patients.
    Sherrard DJ; Goldberg AB; Haas LB; Brunzell JD
    Nephron; 1980; 25(5):219-21. PubMed ID: 7383233
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hyperlipoproteinemia induced by a transplantable pituitary tumor in the rat.
    Nestruck AC; Gianoulakis C; Davignon J; Chrétien M
    Atherosclerosis; 1979 Jan; 32(1):33-42. PubMed ID: 465111
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Idiopathic juvenile cutaneous xanthomatosis with normal blood lipids and low levels of high density lipoprotein-cholesterol].
    Rouffy J; Chanu B; Bakir R; Goy-Loeper J; Brocheriou C; Verola O; Puissant A
    Presse Med; 1984 Apr; 13(17):1099-100. PubMed ID: 6232543
    [No Abstract]   [Full Text] [Related]  

  • 59. The hypocholesterolemic effect of terbufibrol and other drugs in normal and hypercholesterolemic baboons.
    Howard AN; Zschocke R; Löser R; Hofrichter G
    Atherosclerosis; 1979 Apr; 32(4):367-80. PubMed ID: 223594
    [No Abstract]   [Full Text] [Related]  

  • 60. Hypocholesterolaemia in the rat after p-chlorophenoxyisobutyric acid (CPIB) administration as a synthetic triglyceride, 1,3-dipalmitoyl 2(p-chlorophenoxyisobutyroyl)-rac-glycerol.
    Owen JS; Billimoria JD
    Clin Chim Acta; 1977 Sep; 79(2):349-56. PubMed ID: 890970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.